- Concomitant administration of moderate or strong CYP3A4 inhibitors
- Moderate or severe hepatic impairment or active liver disease including unexplained persistent elevations of serum transaminases
The results of the Federal Reserve's June meeting were not a surprise. The central bank left rates unchanged just as Wall Street expected.
Stocks give back gains Wednesday afternoon as Federal Reserve Chair Janet Yellen expresses her confidence in the strength of the U.S. economy.